Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RNTX
Stock Latest News
Company Announcements
Rein Therapeutics Ends Key Financial Agreements
1M ago
8K
RNTX
Premium
Ratings
Rein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
2M ago
RNTX
Premium
Company Announcements
Rein Therapeutics Reports Q3 2025 Financial Results
2M ago
RNTX
Premium
Ratings
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
2M ago
RNTX
Premium
The Fly
Rein Therapeutics announces publication on LTI-03
2M ago
RNTX
Premium
The Fly
Rein Therapeutics upgraded to Buy from Hold at Brookline
2M ago
RNTX
Premium
Company Announcements
Rein Therapeutics Resumes Phase 2 Trial for LTI-03
2M ago
8K
RNTX
Premium
The Fly
Rein Therapeutics receives FDA clearance to resume Phase 2 trial of LTI-03
2M ago
RNTX
Premium
Company Announcements
Rein Therapeutics Secures Third Pre-Paid Advance
3M ago
8K
RNTX
Premium
The Fly
Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03
3M ago
RNTX
Premium
The Fly
Rein Therapeutics initiated with a Buy at H.C. Wainwright
4M ago
RNTX
Premium
The Fly
Rein Therapeutics announces publication of data on LTI-03 in IPF
4M ago
RNTX
Premium
Company Announcements
Rein Therapeutics Secures Second Advance in Funding Deal
4M ago
8K
RNTX
Premium
The Fly
Rein Therapeutics files to sell 10M shares of common stock for holders
4M ago
RNTX
Premium
The Fly
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
5M ago
F
AS
Premium
The Fly
Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
5M ago
LI
TH
Premium
Company Announcements
Rein Therapeutics Gains Approval for Phase 2 Trial
5M ago
8K
RNTX
Premium
The Fly
Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
5M ago
RNTX
Premium
The Fly
Rein Therapeutics downgraded to Hold from Buy at Brookline
5M ago
RNTX
Premium
Company Announcements
Rein Therapeutics Completes Promising IPF Treatment Study
6M ago
RNTX
Premium
Company Announcements
Rein Therapeutics Secures New Financial Agreements
6M ago
8K
RNTX
Premium
The Fly
Rein Therapeutics enters agreements for up to $21M in financing
6M ago
RNTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
